Page last updated: 2024-08-21

maleimide and Acute Myelogenous Leukemia

maleimide has been researched along with Acute Myelogenous Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, M; Chu, T; Larregieu, CA; Li, H; Li, W; Liu, M; Mao, SJ; Yan, B	1

Other Studies

1 other study(ies) available for maleimide and Acute Myelogenous Leukemia

Article	Year
Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity. Molecular pharmaceutics, 2014, Jul-07, Volume: 11, Issue:7 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Daunorubicin; Drug Delivery Systems; Humans; Leukemia, Myeloid, Acute; Liposomes; Maleimides; Mice; Mice, Nude; Peptides; Phosphatidylethanolamines; Polyethylene Glycols; Receptors, LDL; Tissue Distribution	2014

Article

Year

Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity.

Molecular pharmaceutics, 2014, Jul-07, Volume: 11, Issue:7

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Daunorubicin; Drug Delivery Systems; Humans; Leukemia, Myeloid, Acute; Liposomes; Maleimides; Mice; Mice, Nude; Peptides; Phosphatidylethanolamines; Polyethylene Glycols; Receptors, LDL; Tissue Distribution

2014